142 related articles for article (PubMed ID: 7373050)
1. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
Milgrom H; Curd JG; Kaplan RA; Müller-Eberhard HJ; Vaughan JH
J Immunol; 1980 Jun; 124(6):2780-5. PubMed ID: 7373050
[TBL] [Abstract][Full Text] [Related]
2. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
3. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
[TBL] [Abstract][Full Text] [Related]
4. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
6. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
7. The value of rocket immunoelectrophoresis for C4 activation in the evaluation of patients with angioedema or C1-inhibitor deficiency.
Zuraw BL; Sugimoto S; Curd JG
J Allergy Clin Immunol; 1986 Dec; 78(6):1115-20. PubMed ID: 3782676
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
9. Complement activation by antibodies to Sm in systemic lupus erythematosus.
Sabharwal UK; Fong S; Hoch S; Cook RD; Vaughan JH; Curd JG
Clin Exp Immunol; 1983 Feb; 51(2):317-24. PubMed ID: 6601552
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
12. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
[TBL] [Abstract][Full Text] [Related]
13. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
Perrin LH; Shiraishi S; Stroud RM; Lambert PH
J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
[TBL] [Abstract][Full Text] [Related]
15. Chido and Rogers antigenic determinant on the fourth component of human complement.
Chu VF; Marsh WL; Gigli I
J Immunol; 1982 Jan; 128(1):181-5. PubMed ID: 6172476
[TBL] [Abstract][Full Text] [Related]
16. Selective depression of the C4 component of complement: evidence for an association with genetic deficiency of C4 and dermatologic diseases.
Gell J; Tye MJ; Agnello V
Diagn Immunol; 1983; 1(1):49-55. PubMed ID: 6333954
[TBL] [Abstract][Full Text] [Related]
17. Classical and alternative complement pathway activation in paracoccidioidomycosis.
de Messias IT; Mohren D
J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
[TBL] [Abstract][Full Text] [Related]
18. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
[TBL] [Abstract][Full Text] [Related]
19. Determination of complement breakdown fragments C3d and its subfragments in health and disease.
Tamotsu M; Arai K; Fujita S; Hosotsubo K; Hayashi C; Miyai K; Miyano A; Kawanaka K; Takenaka M; Shimizu A
Diagn Immunol; 1984; 2(2):116-21. PubMed ID: 6333963
[TBL] [Abstract][Full Text] [Related]
20. Classical pathway of complement activation in mammalian kidneys.
Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
